Mélanie Gadelorge

1.9k total citations
19 papers, 1.4k citations indexed

About

Mélanie Gadelorge is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Mélanie Gadelorge has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Oncology and 6 papers in Hematology. Recurrent topics in Mélanie Gadelorge's work include Mesenchymal stem cell research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Mélanie Gadelorge is often cited by papers focused on Mesenchymal stem cell research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Mélanie Gadelorge collaborates with scholars based in France, United States and Norway. Mélanie Gadelorge's co-authors include Sandrine Fleury‐Cappellesso, Philippe Bourin, Luc Sensebé, Jill Corre, Michel Attal, Nicolas Espagnolle, Anne Huynh, Bernard Klein, Thierry Rème and Clotaire Danho and has published in prestigious journals such as Blood, Cancer Research and European Journal of Immunology.

In The Last Decade

Mélanie Gadelorge

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélanie Gadelorge France 11 826 482 471 273 267 19 1.4k
E.M. Horwitz United States 7 1.2k 1.5× 761 1.6× 473 1.0× 287 1.1× 160 0.6× 10 1.8k
F C Marini United States 5 1.2k 1.5× 648 1.3× 494 1.0× 250 0.9× 154 0.6× 6 1.6k
Kunimichi Niibe Japan 15 889 1.1× 357 0.7× 531 1.1× 286 1.0× 127 0.5× 22 1.6k
Eva Zetterberg Sweden 15 1.3k 1.6× 704 1.5× 470 1.0× 205 0.8× 134 0.5× 51 2.0k
N. Quirici Italy 15 707 0.9× 422 0.9× 522 1.1× 275 1.0× 97 0.4× 25 1.4k
René Y. McNall United States 4 1.1k 1.3× 525 1.1× 403 0.9× 178 0.7× 151 0.6× 4 1.3k
Sandrine Fleury‐Cappellesso France 15 1.1k 1.4× 625 1.3× 504 1.1× 284 1.0× 400 1.5× 19 2.0k
Maristela Delgado Orellana Brazil 20 1.1k 1.3× 687 1.4× 611 1.3× 327 1.2× 113 0.4× 53 1.8k
Hadi Aslan Israel 9 938 1.1× 490 1.0× 371 0.8× 159 0.6× 115 0.4× 9 1.4k
Krzysztof M. Mrozik Australia 22 735 0.9× 387 0.8× 753 1.6× 231 0.8× 512 1.9× 34 1.7k

Countries citing papers authored by Mélanie Gadelorge

Since Specialization
Citations

This map shows the geographic impact of Mélanie Gadelorge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Gadelorge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Gadelorge more than expected).

Fields of papers citing papers by Mélanie Gadelorge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Gadelorge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Gadelorge. The network helps show where Mélanie Gadelorge may publish in the future.

Co-authorship network of co-authors of Mélanie Gadelorge

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Gadelorge. A scholar is included among the top collaborators of Mélanie Gadelorge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Gadelorge. Mélanie Gadelorge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gadelorge, Mélanie, Maria De Grandis, Frédéric Deschaseaux, et al.. (2024). Human Functional and Tunable in Vitro Model of Healthy and Multiple Myeloma Haematopoietic Niches. Blood. 144(Supplement 1). 2683–2683.
2.
Lemaître, L, Malik Hamaïdia, Mélanie Gadelorge, et al.. (2021). Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth. Blood Advances. 6(2). 672–678. 9 indexed citations
3.
Espagnolle, Nicolas, Benjamin Hébraud, Mélanie Gadelorge, et al.. (2020). Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells. Stem Cells International. 2020. 1–9. 6 indexed citations
4.
Menard, Cédric, Joëlle Dulong, David Roulois, et al.. (2019). Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells. 38(1). 146–159. 60 indexed citations
5.
Gadelorge, Mélanie, et al.. (2016). Clinical-scale expansion of adipose-derived stromal cells starting from stromal vascular fraction in a single-use bioreactor: proof of concept for autologous applications. Journal of Tissue Engineering and Regenerative Medicine. 12(1). 129–141. 9 indexed citations
6.
Chaput, B., Ignacio Garrido, Nicolas Espagnolle, et al.. (2014). A Clinical Scalable Cryopreservation Method of Adipose Tissue for Reconstructive Surgery Assessed by Stromal Vascular Fraction and Mice Studies. Plastic & Reconstructive Surgery. 133(4). 815–826. 8 indexed citations
7.
Bura-Rivière, A., Valérie Planat‐Benard, Philippe Bourin, et al.. (2014). Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 16(2). 245–257. 228 indexed citations
8.
Gadelorge, Mélanie, et al.. (2014). Culture and characterization of mesenchymal stem cells in a totally defined medium. Cytotherapy. 16(4). S106–S106. 1 indexed citations
9.
Espagnolle, Nicolas, Fabien Guilloton, Frédéric Deschaseaux, et al.. (2013). CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. Journal of Cellular and Molecular Medicine. 18(1). 104–114. 114 indexed citations
10.
Sensebé, Luc, Mélanie Gadelorge, & Sandrine Fleury‐Cappellesso. (2013). Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review. Stem Cell Research & Therapy. 4(3). 66–66. 127 indexed citations
11.
Corre, Jill, Nicolas Espagnolle, Benjamin Hébraud, et al.. (2012). Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma. Cancer Research. 72(6). 1395–1406. 76 indexed citations
12.
13.
Laroche, Michel, Philippe Bourin, Jill Corre, et al.. (2012). Dual‐energy X‐ray absorptiometry and biochemical markers of bone turnover after autologous stem cell transplantation in myeloma. European Journal Of Haematology. 88(5). 388–395. 10 indexed citations
14.
Martinet, Ludovic, Sandrine Fleury‐Cappellesso, Mélanie Gadelorge, et al.. (2009). A regulatory cross‐talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells. European Journal of Immunology. 39(3). 752–762. 78 indexed citations
15.
Bourin, Philippe, et al.. (2008). Mesenchymal Progenitor Cells: Tissue Origin, Isolation And Culture. Transfusion Medicine and Hemotherapy. 35(3). 160–167. 26 indexed citations
16.
Kémoun, Philippe, Sara Laurencin‐Dalicieux, Jean‐Christophe Farges, et al.. (2007). Human dental follicle cells acquire cementoblast features under stimulation by BMP-2/-7 and enamel matrix derivatives (EMD) in vitro. Cell and Tissue Research. 329(2). 283–294. 186 indexed citations
17.
Bourin, Philippe & Mélanie Gadelorge. (2007). Les espoirs des cellules souches mésenchymateuses en médecine réparatrice. Transfusion Clinique et Biologique. 14(1). 120–126. 3 indexed citations
18.
Corre, Jill, Karène Mahtouk, Michel Attal, et al.. (2007). Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia. 21(5). 1079–1088. 253 indexed citations
19.
Bourin, Philippe, Jill Corre, Karène Mahtouk, et al.. (2006). Characterization of Mesenchymal Stem Cells Abnormalities in Multiple Myeloma.. Blood. 108(11). 511–511. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.M. Horwitz Breakdown of academic impact, for papers by F C Marini Breakdown of academic impact, for papers by Kunimichi Niibe Breakdown of academic impact, for papers by Eva Zetterberg Breakdown of academic impact, for papers by N. Quirici Breakdown of academic impact, for papers by René Y. McNall Breakdown of academic impact, for papers by Sandrine Fleury‐Cappellesso Breakdown of academic impact, for papers by Maristela Delgado Orellana Breakdown of academic impact, for papers by Hadi Aslan Breakdown of academic impact, for papers by Krzysztof M. Mrozik
Rankless by CCL
2026